EcoDrugPlus

Calcium Voltage-Gated Channel Subunit Alpha1 G

Ensembl ID : ENSSTUG00000010667
Gene Symbol: CACNA1G
3 Cross references
189 Possible Orthologues:

Calcium Voltage-Gated Channel Subunit Alpha1 G

Ensembl ID : ENSSTUG00000048221
Gene Symbol: CACNA1G
3 Cross references
190 Possible Orthologues:

Calcium Voltage-Gated Channel Subunit Alpha1 I

Ensembl ID : ENSSTUG00000034546
Gene Symbol: CACNA1I
3 Cross references
195 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSSTUG00000045826
Gene Symbol: CNR1
3 Cross references
144 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSSTUG00000045691
Gene Symbol: CNR1
1 Cross references
144 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSSTUG00000033385
Gene Symbol: CNR1
3 Cross references
129 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSSTUG00000051053
Gene Symbol: CNR1
3 Cross references
128 Possible Orthologues:

Cannabinoid Receptor 2-Like

Ensembl ID : ENSSTUG00000043585
Gene Symbol: LOC115177130
3 Cross references
185 Possible Orthologues:

Cannabinoid Receptor 2-Like

Ensembl ID : ENSSTUG00000029643
Gene Symbol: LOC115177004
3 Cross references
184 Possible Orthologues:

Carbonic Anhydrase 12

Ensembl ID : ENSSTUG00000015698
Gene Symbol: CA12
1 Cross references
211 Possible Orthologues:

Carbonic Anhydrase 14-Like

Ensembl ID : ENSSTUG00000036164
Gene Symbol: LOC115176937
3 Cross references
201 Possible Orthologues:

Carbonic Anhydrase 14-Like

Ensembl ID : ENSSTUG00000000877
Gene Symbol: LOC115189491
3 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).